Analysis reveals prognostic biomarkers for prostate cancer, indicating potential for improved immunotherapeutic strategies.
We selected a collection of genes relevant to PCa prognosis and immune characteristics, which may serve as potential biomarkers with certain clinical translational value.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: